ALCEDIAG

ALCEDIAG a eu le plaisir d’être invitée aux Journées Filières Numérique en Santé Occitanie ! Benjamin DUBUC est intervenu lors de la session « Innovations numériques de santé : ça bouge en Occitanie ! » organisée par AD'OCC et Eurobiomed, que nous remercions chaleureusement pour leur invitation.   Benjamin a présenté le lancement de l’étude d’utilité clinique, à travers la France, pour le test EDIT-B ® : le 1er test biologique en santé mentale marqué CE et validé cliniquement pour aider à poser précocement un diagnostic différentiel de la #dépression unipolaire et des #troublesbipolaires. L'objectif de cette étude est de démontrer l'impact positif du test sur le diagnostic des patients dépressifs et bipolaires et sa capacité à réduire le fardeau social et économique causé par un diagnostic tardif du trouble bipolaire.   Un grand merci aux organisateurs et à tous les participants pour ces échanges inspirants ! #SantéMentale #Innovation #NumériqueEnSanté

[ 📢 EN] We had an incredible experience at Clariane Innovation Days. We'd like to thank the amazing clinicians and mental health professionals from Clariane clinics for their collaboration in advancing the pilot deployment of the EDIT-B test in routine clinical practice across France, Spain, and Italy in partnership with Synlab. [ 📢 FR] Nous avons vécu une expérience incroyable lors des Clariane Innovation Days. Nous tenons à remercier les excellents cliniciens et professionnels de la santé mentale des cliniques Clariane pour leur collaboration à l'avancement du déploiement pilote du test EDIT-B dans la pratique clinique de routine à travers la France, l'Espagne et l'Italie, en partenariat avec Synlab. [ 📢 IT] Abbiamo vissuto un'esperienza incredibile ai Clariane Innovation Days. Vorremmo ringraziare gli straordinari medici e professionisti della salute mentale delle cliniche Clariane per la loro collaborazione nel portare avanti l'implementazione pilota del test EDIT-B nella pratica clinica di routine in Francia, Spagna e Italia in collaborazione con Synlab. [ 📢 ES] Hemos vivido una experiencia increíble en las Jornadas de Innovación de Clariane. Nos gustaría dar las gracias a los increíbles médicos y profesionales de la salud mental de las clínicas Clariane por su colaboración en el avance del despliegue piloto de la prueba EDIT-B en la práctica clínica habitual en Francia, España e Italia en colaboración con Synlab. #PrecisionPsychiatry #MentalHealth #IVD #Bipolardisorder Clariane | SYNLAB International | SYNLAB Italia | SYNLAB France | SYNLAB España | Ita salud mental | Korian Italia | EIT Health | EIT Health France | EIT Health Spain | EIT Health InnoStars | Eduard Vieta Hospital Clínic de Barcelona | Laurence Ricard | Alexis Bourla | Nicolas Jurado | Aurore S. ANDRE | Samya Benjelloun Touimi | Dolores Montaner Matas | Luca Maria Munari | Antoni Grau Touriño | Antoine Piau | Alexandra Prieux | Fariba Kabirian | Miguel Simón Expósito PhD | antonio sarnicola | Gustavo Faus | Priscilla Clot-Faybesse | Claire Gindre

𝐖𝐡𝐚𝐭 𝐢𝐬 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐏𝐬𝐲𝐜𝐡𝐢𝐚𝐭𝐫𝐲 𝐚𝐧𝐝 𝐡𝐨𝐰 𝐝𝐨𝐞𝐬 𝐢𝐭 𝐝𝐢𝐟𝐟𝐞𝐫 𝐟𝐫𝐨𝐦 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐏𝐬𝐲𝐜𝐡𝐢𝐚𝐭𝐫𝐲? 🚀 We are honored to have taken part yesterday in the Clariane Innovation Days event, dedicated to mental health innovation. It was an honor to have our CEO, Alexandra Prieux , present EDIT-B and the pilot we are doing with Clariane, and participate in a panel discussion with other inspiring startups. We're also grateful to Professor Eduard Vieta from Hospital Clínic de Barcelona for his inspiring keynote address on the latest advancements in precision psychiatry. His insights were invaluable and further solidified our commitment to developing innovative solutions for precision diagnostics in mental health. A special thanks to Clariane for organizing such a fantastic event. We look forward to collaborating with the mental health community and driving more positive change together. Alexis Bourla Nicolas Jurado Aurore S. ANDRE Antoine Piau EIT Health EIT Health Spain SYNLAB France SYNLAB Italia SYNLAB International EIT Health France EIT Health InnoStars #mentalhealth #innovation #PrecisionPsychiatry

We're happy to Join Clariane at their upcoming #InnovationDays on Thursday, November 21st in Barcelona. ALCEDIAG's team will be on site, pitching our innovative technology and the #EDITB test: the first biological diagnostic test to differentiate between depression and bipolar disorder. Prof. Eduard Vieta from the Hospital Clínic de Barcelona, principal investigator in the EDIT-B clinical trial and member of the EDIT-B consortium, will be giving the keynote speech at the event. We are looking forward to engaging with Clariane's network of physicians and talking about the future of #PrecisionPsychiatry. See you in Barcelona!

We're excited to share an invitation to a seminar presenting the EDIT-B test to clinicians in Denmark. 𝗘𝗗𝗜𝗧-𝗕: 𝗔 𝗯𝗹𝗼𝗼𝗱 𝘁𝗲𝘀𝘁 𝘁𝗼 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝘁𝗲 𝗯𝗶𝗽𝗼𝗹𝗮𝗿 𝗱𝗲𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗳𝗿𝗼𝗺 𝘂𝗻𝗶𝗽𝗼𝗹𝗮𝗿 𝗱𝗲𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 🧠 🗓️ 𝗪𝗵𝗲𝗻 & 𝗪𝗵𝗲𝗿𝗲:  Tuesday, 19th November, 3-4 PM, the Auditory building, Hovedvejen 14, Frederiksberg Hospital   𝗔𝗴𝗲𝗻𝗱𝗮: Lars Kessing: Introduction and presentation Dinah Weissmann, CSO ALCEDIAG: AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders.   𝗔𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝗘𝗗𝗜𝗧-𝗕 𝘁𝗲𝘀𝘁 🩸 A major clinical challenge in psychiatry is to differentiate bipolar disorder from unipolar/major depressive disorder, especially during a depressive episode.   During a depressive episode, symptoms appear similar across the two disorders, and the existing clinical scales lack the precision to distinguish between them.   Diagnostic delay and misdiagnosis can lead to inadequate treatment.   Psykiatrisk Center København participates the EIT Health supported #EDITB consortium, investigating whether a blood test can differentiate bipolar depression from unipolar depression through RNA analysis. The EDIT-B blood test is expected to be available for clinical use from 2025. To learn more bout the seminar you can reach out to Jeff Zarp 👇 #PrecisionPsychiatry #IVD #BipolarDisorder #MentalHealthcare

Today we hear the patient's voice of a former dentist, who could not continue to practice. “𝗜 𝘄𝗮𝘀 𝗮 𝗱𝗲𝗻𝘁𝗶𝘀𝘁, 𝗮𝗻𝗱 𝘁𝗵𝗶𝘀 𝗵𝗮𝗱 𝗮 𝗺𝗮𝗷𝗼𝗿 𝗶𝗺𝗽𝗮𝗰𝘁 𝗼𝗻 𝗺𝘆 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀. 𝗜 𝗹𝗼𝘀𝘁 𝗰𝗼𝗻𝗳𝗶𝗱𝗲𝗻𝗰𝗲, 𝗮𝗻𝗱 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝘁𝗼𝗼𝗸 𝗺𝘂𝗰𝗵 𝗹𝗼𝗻𝗴𝗲𝗿 𝗯𝗲𝗰𝗮𝘂𝘀𝗲 𝗜 𝘄𝗮𝘀 𝗮𝗰𝘁𝘂𝗮𝗹𝗹𝘆 𝗶𝗻 𝗮 𝗹𝗼𝘁 𝗼𝗳 𝗽𝗮𝗶𝗻 & 𝗰𝗼𝘂𝗹𝗱𝗻'𝘁 𝗸𝗲𝗲𝗽 𝘂𝗽. 𝗔𝗹𝗹 𝘁𝗵𝗶𝘀 𝗹𝗲𝗱 𝘁𝗼 𝗮 𝗵𝘂𝗴𝗲 𝗹𝗼𝘀𝘀 𝗼𝗳 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀, 𝗮 𝗹𝗼𝘀𝘀 𝗼𝗳 𝘁𝘂𝗿𝗻𝗼𝘃𝗲𝗿, 𝗲𝘁𝗰., 𝗮𝗻𝗱 𝗳𝗶𝗻𝗮𝗹𝗹𝘆 𝘁𝗼 𝘁𝗵𝗲 𝘀𝗮𝗹𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗲 𝗯𝗲𝗰𝗮𝘂𝘀𝗲 𝘁𝗵𝗶𝗻𝗴𝘀 𝘄𝗲𝗿𝗲𝗻'𝘁 𝗴𝗼𝗶𝗻𝗴 𝘄𝗲𝗹𝗹 𝗮𝗻𝘆 𝗺𝗼𝗿𝗲.” Many people affected by bipolar disorder cannot resume their former lives and careers even after being accurately diagnosed and treated. This is especially exacerbated when the diagnosis is delayed and the person continues to suffer, often worsened by inaccurate treatment too. Today's story shines a very bright spotlight on the need for precision psychiatry in diagnostics as well as treatment. #PrecisionPsychiatry #BipolarDisorder #PatientVoices #IVD

Today is the last day of World Mental Health Month 2024. Today we're emphasizing our ongoing commitment as individuals and as a consortium to advancing mental healthcare through precision psychiatry and diagnostics and to improving patients' lives, because in the end, it is all for them. While this year's mental health month has been all about promoting mental health awareness in the workplace, we believe that mental healthcare is a priority in any setting or aspect of life and on any day. We pledge to continue our work, so that the diagnostic gap in mental health and especially in depression and bipolar disorder will be closed and people affected by these condition can balance their health and live their life fully. We take this opportunity to once again thank all of our consortium members and supporters, without whom this would not be possible: SYNLAB International, SYNLAB Italia, SYNLAB France, ProductLife Group, GHU Paris psychiatrie & neurosciences, Capital Region of Denmark, Hospital Clínic de Barcelona, Parc Sanitari Sant Joan de Deu, Fundació Clínic per a la Recerca Biomèdica, Fundació de Recerca Sant Joan de Déu, ALCEN, Azapharm, EIT Health, EIT Health Spain, EIT Health France, EIT Health InnoStars, Eduard Vieta, Chantal Henry, Josep Maria Haro, Jeff Zarp, Lars Kessing, Dinah Weissmann, Diana Vetter, Alexandra Prieux, Aurore S. ANDRE, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) #WorldMentalHealthMonth #WMHM2024 #PrecisionPsychiatry #BipolarDisorder #EDITB

“I was off work for eleven months, then went back to work part-time. What was really complicated was knowing: do I talk about it? Do I bring it up? My team had been taken away from me, and even if the company has human values, I came back in a very complicated situation.” Mental illness is often thought of as a "transparent disability". The people around us may seem ok and healthy, but in reality we have no idea what is going on inside their minds. It may be easier to notice and reach out when it is a close friend or a family member, but what if it's the colleague in the next cubicle? Or the office across the hall? In today's #PatientVoices we hear from a man in his 40's who managed to go back to his previous workplace, but the situation was anything but simple. Maintaining mental health awareness in the workplace starts with each and every one of us not assuming anything about anyone. We need to be mindful of the possibility of a transparent disability and reach out. Don't ignore the issue, but do not make a fuss or stigmatize it too. Be there for each other. #MentalHealthAwareness #WMHM2024 #WorldMentalHealthMonth #BipolarDisorder

This year's World Mental Health Month theme, determined by the World Health Organization is "Mental Health in the workplace". In this article from the WHO, we see just how vital it is to shine a light on the mental health challenges faced by those who care for us: health and care workers. 🏥 Recent findings reveal that 𝟮𝟱% 𝗼𝗳 𝘁𝗵𝗲𝘀𝗲 𝗱𝗲𝗱𝗶𝗰𝗮𝘁𝗲𝗱 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲𝗱 𝗮𝗻𝘅𝗶𝗲𝘁𝘆, 𝗱𝗲𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻, 𝗼𝗿 𝗯𝘂𝗿𝗻𝗼𝘂𝘁 during the COVID-19 pandemic, and unfortunately, many continue to struggle even after its official end. The emotional toll of compassion fatigue, coupled with systemic issues like heavy workloads and limited flexibility, has created a mental health crisis that cannot be ignored. 𝙺̲𝚎̲𝚢̲ ̲𝙵̲𝚊̲𝚌̲𝚝̲𝚘̲𝚛̲𝚜̲ ̲𝙲̲𝚘̲𝚗̲𝚝̲𝚛̲𝚒̲𝚋̲𝚞̲𝚝̲𝚒̲𝚗̲𝚐̲ ̲𝚝̲𝚘̲ ̲𝙼̲𝚎̲𝚗̲𝚝̲𝚊̲𝚕̲ ̲𝙷̲𝚎̲𝚊̲𝚕̲𝚝̲𝚑̲ ̲𝙲̲𝚑̲𝚊̲𝚕̲𝚕̲𝚎̲𝚗̲𝚐̲𝚎̲𝚜̲:̲ • 𝗛𝗶𝗴𝗵-𝗦𝘁𝗿𝗲𝘀𝘀 𝗘𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁: Healthcare settings are inherently stressful, with long hours and life-or-death decisions weighing heavily on workers. • 𝗖𝗼𝗺𝗽𝗮𝘀𝘀𝗶𝗼𝗻 𝗙𝗮𝘁𝗶𝗴𝘂𝗲 𝗮𝗻𝗱 𝗧𝗿𝗮𝘂𝗺𝗮: Continuous exposure to traumatic experiences can lead to emotional exhaustion. • 𝗦𝘆𝘀𝘁𝗲𝗺𝗶𝗰 𝗜𝘀𝘀𝘂𝗲𝘀: Heavy workloads and insufficient support systems contribute significantly to decreased job satisfaction and increased absenteeism. Experts stress the urgency of addressing these challenges. 𝗣𝗿𝗶𝗼𝗿𝗶𝘁𝗶𝘇𝗶𝗻𝗴 𝗺𝗲𝗻𝘁𝗮𝗹 𝗿𝗲𝘀𝗶𝗹𝗶𝗲𝗻𝗰𝗲 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗰𝗼𝘂𝗻𝘀𝗲𝗹𝗶𝗻𝗴, 𝗰𝗼𝗮𝗰𝗵𝗶𝗻𝗴, 𝗮𝗻𝗱 𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘇𝗶𝗻𝗴 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹 𝗹𝗶𝗳𝗲 𝘀𝘁𝗿𝗲𝘀𝘀𝗼𝗿𝘀 𝗶𝘀 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹. Organizations must invest in workforce well-being— not as an option but as a necessity. Providing timely counseling and fostering a culture of open discussion can help prevent burnout and save resources in the long run. Read more in the article below 👇 #MentalHealthAwareness #HealthcareWorkers #WorkplaceWellbeing #WorldMentalHealthMonth #WMHM2024

Our CEO, Alexandra Prieux, is speaking on stage at the Unconference, organized by Catalonia.Health (CataloniaBio & HealthTech) with support from the EIT Health to discuss the future of healthcare solutions, with the aim of fostering awareness, perspective and vision of the sector's needs and opportunities, and how best to address them. The event, moderated by Javier Selva (CEO CATALONIA.HEALTH) & Izabel Alfany (Managing Director EIT Health Spain), features interesting discussions about barriers and enablers for AI in the European landscape, and prominent speakers including: Yamelis Figueredo, Global Chief Digital & Information Officer, Grifols; Josh Callan, Spain Manager, Business Solutions & Strategy, Veeva Systems; Enrique Lizaso Olmos CEO, Multiverse Computing; Board member, European QulC; Julien Venne Director of New Opportunities and Business Development, EIT Health and others. #HealthcareInnovation #AI #HealthTech